Business, energy, technology, markets and global industry news from Business News Today

Medical Devices & Diagnostics

PharmaDeviceNews Medical Devices & Diagnostics
Representative image: Clinicians review lung cancer genomic testing data and blood-based diagnostic results, reflecting Guardant Health’s Guardant360 CDx FDA approval as a companion diagnostic for HERNEXEOS in HER2-mutant advanced non-small cell lung cancer.
Medical Devices & Diagnostics

How Guardant360 CDx approval supports Boehringer Ingelheim’s HERNEXEOS launch strategy

Find out how Guardant360 CDx approval could expand liquid biopsy use in HER2-mutant advanced lung cancer treatment selection.

Read More
Representative image of EEG-guided brain stimulation as Wave Neuroscience’s MeRT FDA clearance puts biomarker-led PTSD treatment, neuromodulation, and precision psychiatry under sharper focus.
Medical Devices & Diagnostics

Wave Neuroscience FDA clearance puts EEG-guided PTSD treatment closer to clinical adoption

Find out how Wave Neuroscience’s MeRT FDA clearance could reshape biomarker-guided PTSD treatment and precision psychiatry.

Read More
Representative image: Clinicians review a chest CT scan as AI-assisted lung nodule risk assessment gains attention through Tanner Health’s Optellum rollout, highlighting the push to improve early lung cancer triage in regional care.
Medical Devices & Diagnostics

Why Optellum’s deployment at Tanner Health could matter for lung cancer risk stratification

Find out how Tanner Health’s Optellum rollout could reshape AI lung nodule triage and early lung cancer detection in regional care.

Read More
Representative image of CT imaging analysis as Subtle Medical’s SubtleHD(CT) FDA clearance puts AI-powered image enhancement, radiology workflows, and scanner efficiency under sharper focus.
Medical Devices & Diagnostics

Subtle Medical wins FDA clearance for CT software as scanner pressure intensifies

Find out how Subtle Medical’s FDA-cleared SubtleHD(CT) could reshape AI-powered CT image enhancement and radiology workflows.

Read More
FDA clearance for Rubina Lens gives KARL STORZ a sharper open surgery proposition
Medical Devices & Diagnostics

Could KARL STORZ’s Rubina Lens turn open surgery into the next imaging battleground?

Find out how KARL STORZ’s Rubina Lens FDA clearance could expand fluorescence imaging in open surgery and hospital workflows.

Read More
Representative image: Non-invasive elbow therapy highlights MR5 ACTIV PRO’s FDA-cleared role in temporary tennis elbow pain relief.
Medical Devices & Diagnostics

Why Multi Radiance Medical’s MR5 ACTIV PRO clearance matters for tendon pain treatment

Read how Multi Radiance Medical’s MR5 ACTIV PRO clearance could reshape non-invasive tennis elbow pain treatment and what risks remain.

Read More
Representative image: A PET/CT imaging suite illustrates how Pentixapharm’s [68Ga]Ga-PentixaFor Phase 3 PANDA study could reshape primary aldosteronism diagnostics and cardiovascular precision medicine.
Medical Devices & Diagnostics

Why a CXCR4 PET/CT tracer could become Pentixapharm’s most important cardiovascular asset

See why Pentixapharm’s Phase 3 CXCR4 PET/CT push could challenge a stubborn diagnostic bottleneck in primary aldosteronism.

Read More
Xenix Medical’s expandable lumbar fusion push now faces the real commercial trial
Medical Devices & Diagnostics

Xenix Medical’s Lux system targets a key pain point in lumbar fusion surgery

Lux gives Xenix Medical a lumbar fusion opening. Read why adoption, evidence and surgeon workflow now matter most.

Read More
Representative image of an intensive care unit ventilator setup, highlighting how diaphragm stimulation devices such as Lungpacer Medical’s AeroPace System could help hospitals support faster ventilator weaning in critically ill patients.
Medical Devices & Diagnostics

Can Lungpacer Medical’s AeroPace System change the economics of ventilator recovery?

AeroPace moves into East Coast ICU care as hospitals test whether diaphragm stimulation can shorten ventilator recovery. Read the analysis.

Read More
Representative image: A noninvasive colorectal cancer screening kit in a clinical setting, reflecting how Medicare coverage for Geneoscopy’s ColoSense could expand access to stool RNA-based colorectal cancer testing.
Medical Devices & Diagnostics

Geneoscopy’s ColoSense Medicare win puts stool RNA testing into the colorectal screening mainstream

Medicare coverage gives ColoSense a bigger test: can stool RNA screening move from FDA approval to real colorectal cancer adoption?

Read More